Applied Graphene Materials, a producer of specialty graphene materials, including graphene nanoplatelets, has announced its interim results for the period ended 31 January 2016.
The company reported an EBITDA Loss of £2.1 million, compared to a loss of £1.8 million in 2015. Cash at bank was £10.2 million, compared to £6.6 million in 2015.
‘As the business pursues production orders we have made strong progress during the period in the key areas of graphene formulation know-how and strengthening our commercial pipeline,’ said Jon Mabbitt, CEO. ‘In January we were pleased to successfully raise £8.5 million, from existing and new shareholders, and have since made progress on scaling up the group’s production facilities to increase manufacturing capacity. We continue to be focused on three target market sectors where we believe our products can add most value and where we see large scale and long term commercial opportunity.’
This story uses material from Applied Graphene Materials, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.
